X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (14) 14
index medicus (9) 9
humans (8) 8
melanoma (7) 7
metastasis (7) 7
cancer (6) 6
immunotherapy (6) 6
surgery (5) 5
aged (4) 4
aged, 80 and over (4) 4
care and treatment (4) 4
chemotherapy (4) 4
female (4) 4
hematology, oncology and palliative medicine (4) 4
male (4) 4
antibodies, monoclonal - adverse effects (3) 3
braf (3) 3
disease-free survival (3) 3
drug therapy (3) 3
medicine & public health (3) 3
open-label (3) 3
tumors (3) 3
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - radiotherapy (2) 2
adult (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
carcinoma, squamous cell - drug therapy (2) 2
carcinoma, squamous cell - pathology (2) 2
chemotherapy, adjuvant (2) 2
clinical trial (2) 2
clinical trials (2) 2
cutaneous melanoma (2) 2
dermatology (2) 2
drug dosages (2) 2
efficacy (2) 2
esophageal cancer (2) 2
esophageal neoplasms - radiotherapy (2) 2
esophagogastric junction - radiation effects (2) 2
health aspects (2) 2
immune checkpoint (2) 2
ipilimumab (2) 2
meeting abstracts (2) 2
melanoma - pathology (2) 2
metastases (2) 2
metastatic melanoma (2) 2
middle aged (2) 2
neoplasm staging (2) 2
older people (2) 2
practice guidelines as topic (2) 2
prognosis (2) 2
radiotherapy (2) 2
randomized-trial (2) 2
research (2) 2
skin neoplasms - pathology (2) 2
studies (2) 2
survival (2) 2
1st-line treatment (1) 1
abridged index medicus (1) 1
adenocarcinoma (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
adjuvant radiotherapy (1) 1
adjuvant therapy (1) 1
adoptive cell therapy (1) 1
adult intussusception (1) 1
advanced esophagogastric cancer (1) 1
advanced gastroesophageal cancer (1) 1
aged patients (1) 1
algorithms (1) 1
angiogenesis inhibitors (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anti-pd-1 antibody (1) 1
antibodies, monoclonal, humanized (1) 1
antigen-4 blockade (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor-activity (1) 1
autoimmunity (1) 1
aya (1) 1
bevacizumab (1) 1
blockade (1) 1
blood (1) 1
body weight (1) 1
bowel resection (1) 1
braf inhibitor resistance (1) 1
brain (1) 1
brain metastases (1) 1
cancer patients (1) 1
cancer surgery (1) 1
cancer therapies (1) 1
capecitabine (1) 1
carboplatin - administration & dosage (1) 1
carcinoma (1) 1
carcinoma - drug therapy (1) 1
carcinoma - mortality (1) 1
carcinoma, squamous cell - radiotherapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 375 - 384
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2008, Volume 83, Issue 6, pp. 712 - 722
Upper gastrointestinal tumors involving the esophagus and the stomach are a serious public health problem worldwide. The West has seen a dramatic increase in... 
Internal Medicine
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017, Volume 98, Issue 1, pp. 16 - 17
Journal Article
by Lundqvist, Andreas and van Hoef, Vincent and Zhang, Xiaonan and Wennerberg, Erik and Lorent, Julie and Witt, Kristina and Sanz, Laia Masvidal and Liang, Shuo and Murray, Shannon and Larsson, Ola and Kiessling, Rolf and Mao, Yumeng and Sidhom, John-William and Bessell, Catherine A and Havel, Jonathan and Schneck, Jonathan and Chan, Timothy A and Sachsenmeier, Eliot and Woods, David and Berglund, Anders and Ramakrishnan, Rupal and Sodre, Andressa and Weber, Jeffrey and Zappasodi, Roberta and Li, Yanyun and Qi, Jingjing and Wong, Philip and Sirard, Cynthia and Postow, Michael and Newman, Walter and Koon, Henry and Velcheti, Vamsidhar and Callahan, Margaret K and Wolchok, Jedd D and Merghoub, Taha and Lum, Lawrence G and Choi, Minsig and Thakur, Archana and Deol, Abhinav and Dyson, Gregory and Shields, Anthony and Haymaker, Cara and Uemura, Marc and Murthy, Ravi and James, Marihella and Wang, Daqing and Brevard, Julie and Monaghan, Catherine and Swann, Suzanne and Geib, James and Cornfeld, Mark and Chunduru, Srinivas and Agrawal, Sudhir and Yee, Cassian and Wargo, Jennifer and Patel, Sapna P and Amaria, Rodabe and Tawbi, Hussein and Glitza, Isabella and Woodman, Scott and Hwu, Wen-Jen and Davies, Michael A and Hwu, Patrick and Overwijk, Willem W and Bernatchez, Chantale and Diab, Adi and Massarelli, Erminia and Segal, Neil H and Ribrag, Vincent and Melero, Ignacio and Gangadhar, Tara C and Urba, Walter and Schadendorf, Dirk and Ferris, Robert L and Houot, Roch and Morschhauser, Franck and Logan, Theodore and Luke, Jason J and Sharfman, William and Barlesi, Fabrice and Ott, Patrick A and Mansi, Laura and Kummar, Shivaani and Salles, Gilles and Carpio, Cecilia and Meier, Roland and Krishnan, Suba and McDonald, Dan and Maurer, Matthew and Gu, Xuemin and Neely, Jaclyn and Suryawanshi, Satyendra and Levy, Ronald and Khushalani, Nikhil and Wu, Jennifer and Zhang, Jinyu and Basher, Fahmin and Rubinstein, Mark and Bucsek, Mark and Qiao, Guanxi and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
by Althammer, Sonja and Steele, Keith and Rebelatto, Marlon and Tan, Tze Heng and Wiestler, Tobias and Schmidt, Guenter and Higgs, Brandon and Li, Xia and Shi, Li and Jin, Xiaoping and Antal, Joyce and Gupta, Ashok and Ranade, Koustubh and Binning, Gerd and Bellmunt, Joaquim and de Wit, Ronald and Vaughn, David J and Fradet, Yves and Lee, Jae Lyun and Fong, Lawrence and Vogelzang, Nicholas J and Climent, Miguel A and Petrylak, Daniel P and Choueiri, Toni K and Necchi, Andrea and Gerritsen, Winald and Gurney, Howard and Quinn, David I and Culine, Stéphane and Sternberg, Cora N and Mai, Yabing and Puhlmann, Markus and Perini, Rodolfo F and Bajorin, Dean F and Sharma, Padmanee and Callahan, Margaret K and Calvo, Emiliano and Kim, Joseph W and de Braud, Filipo and Ott, Patrick A and Bono, Petri and Pillai, Rathi N and Morse, Michael and Le, Dung T and Taylor, Matthew and Spilliopoulou, Pavlina and Bendell, Johanna and Jaeger, Dirk and Chan, Emily and Antonia, Scott J and Ascierto, Paolo A and Hennicken, Delphine and Tschaika, Marina and Azrilevich, Alex and Rosenberg, Jonathan and Levy, Ofer and Chan, Christopher and Cojocaru, Gady and Liang, Spencer and Ophir, Eran and Ganguly, Sudipto and Toporik, Amir and Kotturi, Maya and Kfir, Tal Fridman and Murter, Benjamin M and Logronio, Kathryn and Dassa, Liat and Leung, Ling and Greenwald, Shirley and Azulay, Meir and Kumar, Sandeep and Alteber, Zoya and Pan, Xiaoyu and Machlenkin, Arthur and Benita, Yair and Drake, Andrew W and Chajut, Ayelet and Salomon, Ran and Vankin, Ilan and Safyon, Einav and Hunter, John and Levine, Zurit and White, Mark and Leidner, Rom and Kang, Hyunseok and Haddad, Robert and Segal, Neil H and Wirth, Lori J and Ferris, Robert L and Hodi, F. Stephen and Sanborn, Rachel E and Gajewski, Thomas F and Sharfman, William and McDonald, Dan and Srivastava, Shivani and Gu, Xuemin and Phillips, Penny and Passey, Chaitali and Seiwert, Tanguy and Habtetsion, Tsadik and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 12/2016, Volume 4, Issue S2
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 2013, Volume 11, Issue 4, pp. 395 - 407
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 4, pp. 341 - 351
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 2014, Volume 12, Issue 5, pp. 621 - 629
The NCCN Guidelines for Melanoma provide multidisciplinary recommendations for the management of patients with melanoma. These NCCN Guidelines Insights... 
MEK INHIBITION | LYMPHADENECTOMY | ONCOLOGY | HIGH-RISK | CUTANEOUS MELANOMA | IMPROVED SURVIVAL | PHASE-II | OPEN-LABEL | BRAF | ADJUVANT RADIOTHERAPY | RADIATION-THERAPY
Journal Article
Journal of Carcinogenesis, ISSN 0974-6773, 01/2014, Volume 13, Issue 1, pp. 1 - 1
Until recently, options for therapy in metastatic melanoma were limited. The understanding of immune check-point blockade and the discovery of molecular... 
melanoma | MEK | BRAF | immunotherapy
Journal Article
Cancer Medicine, ISSN 2045-7634, 04/2018, Volume 7, Issue 4, pp. 991 - 996
Clinical trial enrollments in adolescents and young adults (AYA) with cancer have historically been lower than those in pediatric and older adult populations.... 
clinical trial | AYA | melanoma | BRAF | immunotherapy | Young adults | Immune checkpoint | Enrollments | Older people | Melanoma | Clinical trials | Metastasis | Cancer
Journal Article
Oncology, ISSN 0030-2414, 07/2013, Volume 85, Issue 1, pp. 53 - 58
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 06/2019, Volume 119, Issue 7, pp. 897 - 902
Background Increased cross‐sectional imaging for surveillance of metastatic melanoma has led to more diagnoses of asymptomatic intussusception. Methods We... 
melanoma | metastatic melanoma, surgery | bowel resection | intussusception | ADULT INTUSSUSCEPTION | ONCOLOGY | metastatic melanoma | MALIGNANT-MELANOMA | surgery | Medical research | Care and treatment | Intestines | Intussusception | Melanoma | Medicine, Experimental | Medical records | Metastasis | Health aspects
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2008, Volume 71, Issue 3, pp. 242 - 248
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 3/2011, Volume 12, Issue 1, pp. 107 - 107
Journal Article